Association of Life's Essential 8 Score with All-Cause and Cardiovascular Mortality in Patients with Diabetic Nephropathy: A NHANES-Based Cohort Study

生命必需8项评分与糖尿病肾病患者全因死亡率和心血管死亡率的相关性:一项基于NHANES的队列研究

阅读:2

Abstract

PURPOSE: This study aimed to assess the relationship between the "Life's Essential 8" (LE8) score and all-cause and cardiovascular mortality in patients with diabetic nephropathy (DN). METHODS: This observational cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES, 2005-2018). A total of 1,745 patients with DN were included. The LE8 score encompassed health behaviors (diet, physical activity, nicotine control, sleep) and physiological indices (body mass index, non-high-density lipoprotein cholesterol, blood glucose, blood pressure). A multivariate Cox proportional risk model was employed to assess the effect of the LE8 score on the risk of death, and the dose-response relationship was analyzed by a restricted cubic spline (RCS) model. Subgroup analyses and multiple imputations were performed to verify the robustness of the findings. RESULTS: After adjusting for confounders, a 10-point increase in the LE8 score was associated with a 12% reduction in the risk of all-cause mortality [hazard ratio (HR) = 0.88, P < 0.001] and a 16% reduction in the risk of cardiovascular death (HR = 0.84, P = 0.007). The risk of all-cause mortality was 33% lower in the highest tertile group compared with the lowest group (HR = 0.67, P < 0.001), and the risk of cardiovascular mortality was 36% lower (HR = 0.64, P = 0.014). RCS analysis showed that LE8 scores were linearly negatively correlated with mortality (nonlinear P > 0.05). Subgroup analyses further confirmed the consistency of this association across various characteristic subgroups. CONCLUSION: LE8 score has been identified as an independent protective factor for the risk of death in patients with DN, exhibiting a linear dose-response relationship consistent across sociodemographic subgroups. This finding underscores the importance of incorporating LE8 into a comprehensive assessment system for DN patients, providing a foundation for precision intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。